Interleukin 2 in cancer therapy

The goal of adoptive immunotherapy is the stimulation of host antitumor immunity, either cellular or humoral. The introduction of recombinant human cytokines into clinical oncology represents a new useful tool for the development of new strategies of antitumor immunotherapy. This article describes t...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Annali dell'Istituto superiore di sanità 1990, Vol.26 (3-4), p.283-334
Hauptverfasser:	Testa, U, Montesoro, E, Bulgarini, D, Samoggia, P, Masciulli, R, Habetswallner, D, Carè, A, Mariani, G, Giannella, G, Boccoli, G
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Animals Child Drug Evaluation Humans Immunologic Factors - therapeutic use Immunotherapy, Adoptive Interleukin-2 - administration & dosage Interleukin-2 - adverse effects Interleukin-2 - therapeutic use Killer Cells, Lymphokine-Activated - immunology Killer Cells, Lymphokine-Activated - transplantation Killer Cells, Natural - drug effects Killer Cells, Natural - immunology Lymphocyte Activation Lymphocytes, Tumor-Infiltrating - immunology Lymphocytes, Tumor-Infiltrating - transplantation Mice Neoplasms - therapy Neoplasms, Experimental - therapy Receptors, Interleukin-2 - drug effects Receptors, Interleukin-2 - physiology Recombinant Proteins - therapeutic use T-Lymphocytes - immunology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!